grant

Therapeutic approaches to treat human immunodeficiency virus infection: development of HIV-1 integrase inhibitors [ 2007-01-19 - 2009-12-31 ]

Research Grant

[Cite as https://purl.org/au-research/grants/arc/LP0775192]

Researchers: Dr David Chalmers (Chief Investigator) ,  Martin Scanlon (Chief Investigator) ,  Martin Scanlon (Chief Investigator) ,  Dr David Rhodes (Partner Investigator) ,  Dr John Deadman (Partner Investigator)
View all 6 related researchers

Brief description Therapeutic approaches to treat human immunodeficiency virus infection: development of HIV-1 integrase inhibitors. This project aims to assist the development of new anti-HIV drugs, which would benefit the 15000 Australians and over 40 million people worldwide who are currently infected with this terrible disease. The project will utilise state of the art technologies - including the Australian Synchrotron when it is commissioned in 2007 - to identify and synthesise compounds as new leads for the treatment of HIV.

Funding Amount $377,513

Funding Scheme Linkage Projects

View this grant in the ARC Data Portal

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]